Login / Signup

Mortality Benefit of Methylene Blue in Critically Ill and Perioperative Patients: A Revised Trial Sequential Analysis.

I-Wen ChenTing-Sian YuKuo-Chuan Hung
Published in: Journal of cardiothoracic and vascular anesthesia (2024)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • clinical trial
  • patients undergoing
  • randomized controlled trial
  • risk factors
  • phase ii
  • coronary artery disease